Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay-Reference-Cited by-同舟云学术

Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay

Published:2020-02-10 Issue:6 Volume:34 Page:671-682
ISSN:0920-654X
Container-title:Journal of Computer-Aided Molecular Design
language:en
Short-container-title:J Comput Aided Mol Des

Author:

Rajan Ravi Kumar,Ramanathan M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Physical and Theoretical Chemistry,Computer Science Applications,Drug Discovery

Link

http://link.springer.com/content/pdf/10.1007/s10822-020-00297-y.pdf

Reference40 articles.

1. Pandian JD, Sudhan P (2013) Stroke epidemiology and stroke care services in India. J Stroke 15:128. https://doi.org/10.5853/jos.2013.15.3.128

2. Feigin VL, Krishnamurthi RV, Parmar P et al (2015) Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: the GBD 2013 Study. Neuroepidemiology 45:161–176. https://doi.org/10.1159/000441085

3. Shao S, Xu M, Zhou J et al (2017) Atorvastatin attenuates ischemia/reperfusion-induced hippocampal neurons injury via Akt-nNOS-JNK signaling pathway. Cell Mol Neurobiol 37:753–762. https://doi.org/10.1007/s10571-016-0412-x

4. Kuan C-Y, Whitmarsh AJ, Yang DD et al (2003) A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci 100:15184–15189. https://doi.org/10.1073/pnas.2336254100

5. Messoussi A, Feneyrolles C, Bros A et al (2014) Recent progress in the design, study, and development of c-Jun N-terminal kinase inhibitors as anticancer agents. Chem Biol 21:1433–1443. https://doi.org/10.1016/j.chembiol.2014.09.007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential JNK3 inhibitors through virtual screening, molecular docking and molecular dynamics simulation as therapeutics for Alzheimer’s disease;Molecular Diversity;2024-04-04

2. Piceatannol selectively inhibited the JNK3 enzyme and augmented apoptosis through inhibition of Bcl‐2/Cyt‐c/caspase‐dependent pathways in the oxygen–glucose deprived SHSY‐5Y cell lines: In silico and in vitro study;Chemical Biology & Drug Design;2024-02

3. Piceatannol improved cerebral blood flow and attenuated JNK3 and mitochondrial apoptotic pathway in a global ischemic model to produce neuroprotection;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-07-20

4. C–Glucosyl Xanthone derivative Mangiferin downregulates the JNK3 mediated caspase activation in Almal induced neurotoxicity in differentiated SHSY-5Y neuroblastoma cells;Toxicology Mechanisms and Methods;2023-07-19

5. Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease;European Journal of Medicinal Chemistry;2023-01